Bley Nadine

Head of Core Facility Imaging

Martin Luther University Halle-Wittenberg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Bley Nadine serves as the Head of Core Facility Imaging at Martin Luther University Halle/Wittenberg in Germany. Her research predominantly focuses on the roles of long non-coding RNAs and RNA-binding proteins in cancer development, including pancreatic and ovarian cancers. Notable contributions include investigations into the oncogenic potential of various proteins and their implications in tumor biology and cellular processes.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Eduard Sabidó

Head

SPAIN

View details

Stefan Hüttelmaier

Martin Luther University Halle-Wittenberg

GERMANY

View details

David Schwefel

GERMANY

View details

Danny Misiak

Martin Luther University Halle-Wittenberg

GERMANY

View details

Caterina Mancarella

IRCCS Istituto Ortopedico Rizzoli

ITALY

View details

Christian P. Pallasch

Professor

University Hospital Düsseldorf

GERMANY

View details

Stefan Kempa

Head

GERMANY

View details

Markus Landthaler

Humboldt-Universität zu Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bley Nadine

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Long Non-Coding RNAs and RNA-Binding Proteins in Pancreatic Cancer Development and Progression.

The IGF2BP1 oncogene is a druggable m<sup>6</sup>A-dependent enhancer of YAP1-driven gene expression in ovarian cancer.

RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing

Editorial: RNA-binding proteins in cancer: advances in translational research.

IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.

The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL

Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis

HDLBP binds ER-targeted mRNAs by multivalent interactions to promote protein synthesis of transmembrane and secreted proteins.

Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia

Oncogenic Potential of the Dual-Function Protein MEX3A.

Collaborators (8)

Eduard Sabidó

Stefan Hüttelmaier

David Schwefel

Danny Misiak

Caterina Mancarella

Christian P. Pallasch

Stefan Kempa

Markus Landthaler

Make your next move.

Bley Nadine

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Long Non-Coding RNAs and RNA-Binding Proteins in Pancreatic Cancer Development and Progression.

The IGF2BP1 oncogene is a druggable m&lt;sup&gt;6&lt;/sup&gt;A-dependent enhancer of YAP1-driven gene expression in ovarian cancer.

RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing

Editorial: RNA-binding proteins in cancer: advances in translational research.

IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression.

The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL

Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis

HDLBP binds ER-targeted mRNAs by multivalent interactions to promote protein synthesis of transmembrane and secreted proteins.

Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia

Oncogenic Potential of the Dual-Function Protein MEX3A.

Collaborators (8)

Eduard Sabidó

Stefan Hüttelmaier

David Schwefel

Danny Misiak

Caterina Mancarella

Christian P. Pallasch

Stefan Kempa

Markus Landthaler

Make your next move.

The IGF2BP1 oncogene is a druggable m<sup>6</sup>A-dependent enhancer of YAP1-driven gene expression in ovarian cancer.